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Abstract The inaccuracy of arterial waveform analysis
for measuring continuos cardiac output (CCO) associated
with changes in systemic vascular resistance (SVR) has
been well documented. A new non-invasive continuous
cardiac output monitoring system (esCCO) mainly utilizing
pulse wave transit time (PWTT) in place of arterial
waveform analysis has been developed. However, the
trending ability of esCCO to measure cardiac output during
changes in SVR remains unclear. After a previous multi-
center study on esCCO measurement, we retrospectively
identified two cases in which apparent changes in SVR
developed in a short period during data collection. In each
case, the trending ability of esCCO to measure cardiac
output and time component of PWTT were analyzed.
Recorded data suggest that the time component of PWTT
may have a significant impact on the accuracy of esti-
mating stroke volume during changes in SVR. However,
further prospective clinical studies are required to test this
hypothesis.
Keywords Cardiac output  Measurement
technique  Pulse wave transit time  Systemic
vascular resistance
1 Introduction
Non-invasive continuous cardiac output (CCO) monitors have
become popular in operating rooms and intensive care units
(ICUs). However, the inaccuracy of arterial waveform ana-
lysis for measuring CCO associated with changes in systemic
vascular resistance (SVR) has been well documented [1, 2].
Sugo et al. [3] developed a new non-invasive CCO monitoring
system called estimated continuous cardiac output (esCCO).
In the esCCO system, CCO is derived by means of a con-
ventional electrocardiogram (ECG) monitor, peripheral pulse
oximetry (SpO2) system, and arterial pulse pressure. The
esCCO system uses pulse wave transit time (PWTT) in place
of arterial waveform analysis. PWTT is the sum of the pre-
ejection period (PEP) and the time taken for pulse wave to
travel from the ascending aorta to the SpO2 probe site (Fig. 1).
PWTT is calculated from the interval between the R wave
peak of the ECG and the rise point of peripheral SpO2 pulse
wave when the ECG and SpO2 are recorded simultaneously.
Stroke volume (SV) is derived as follows:
SV ¼ K  ða PWTT þ bÞ
Here, a is an experimental constant. K and b are derived
from PWTT, heart rate, pulse pressure, and cardiac output
(CO) at the start of measurement for each patient.
Accordingly, the esCCO system requires a continuous
measurement of PWTT, but not MAP after the start of
measurement to calculate CCO.
There have been no clinical studies on the esCCO sys-
tem concerning CCO estimation during changes in SVR or
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on the impact of the time component of PWTT on the
estimation of CO, even though changes in SVR would have
a less impact on esCCO system compared to CCO mea-
surement system with arterial waveform analysis [4]. In our
previous multicenter studies [4–6], we identified two cases
in which apparent changes in SVR developed in a short
period of time during data collection. In this report, we
retrospectively analyze the time component of peripheral
wave transmission in these two cases, and examined the
contribution of the time component of PWTT in determi-
nation of SV and CO.
2 Case history
The esCCO system was connected to a conventional ECG
monitor, radial artery pressure monitor, and SpO2 system.
A CCO monitor derived data from a flow directional pul-
monary artery catheter (Swan-Ganz CCOmbo CCO/SVO2,
ref. 744HF75, Baxter Healthcare, Edwards Critical Care
Division, Irvine, CA) and was connected to the esCCO
system. SVR is calculated continuously from CO, mean
arterial pressure (MAP), and CVP using a standard for-
mula. Additionally, the amplitude of SpO2 pulse wave was
measured continuously, as described by Murray et al. [7].
2.1 Case 1
A 79-year-old male with height of 167.5 cm and preopera-
tive body weight of 52.8 kg underwent removal of a pan-
creatic tumor. Total intravenous anesthesia with propofol
and remifentanil combined with continuous epidural block
using 6 ml/h of 1.0 % carbocaine was given to the patient.
Approximately 2 h before completion of the surgical pro-
cedure, MAP started to gradually decrease and reached
61 mmHg at 20:00, and the carbocaine infusion was swit-
ched to 0.2 % ropivacaine infusion (5 ml/h). The lowest
MAP of 55 mmHg was recorded at 20:09, and MAP grad-
ually increased thereafter. While CCO decreased from 6.5 to
5.2 L/min (Fig. 2, Interval A: 20:15–20:45), SVR increased
from 640 to 1,100 dyne s cm-5. esCCO decreased from 8.3
to 6.8 L/min, and the amplitude of the SpO2 pulse wave also
decreased.
2.2 Case 2
A 61-year-old male with height of 158.5 cm and preoper-
ative body weight of 56.9 kg underwent quadruple off-
pump coronary artery bypass grafting. MAP increased, and
SV slightly decreased immediately after the patient was
admitted postoperatively to the ICU. SVR increased from
Fig. 2 Trends in circulatory
parameters in Case 1 (Interval
A) Blue heart rate (HR); Red
mean arterial pressure (MAP);
Green estimated continuous
cardiac output (esCCO); Brown
continuous cardiac output
derived from a flow directional
pulmonary artery catheter
(CCO); Purple systemic
vascular resistance (SVR);
Black pulse amplitude
(normalized SpO2 pulse wave
amplitude)
Fig. 1 Relationship between each time-related component of pulse
wave transit time. PWTT pulse wave transit time, SpO2 peripheral
pulse oximetry, PEP pre-ejection period, PWTT1 transit time from the
rising point of the aortic root pressure wave to the rising point of the
radial artery pressure wave in the systolic phase, PWTT2 transit time
from the rising point of the radial artery wave to the rising point of the
SpO2 pulse wave in the systolic phase
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1,700 to 2,500 dyne s cm-5, but neither CCO nor esCCO
was obviously changed (Fig. 3, Interval B). The amplitude
of the SpO2 pulse wave decreased. Subsequently, 0.5 mg of
IV nicardipine was injected and resulted in a decrease in
MAP from 110 to 89 mmHg, associated with an increase in
CCO from 4.0 to 4.5 L/min. SVR decreased from 2,500 to
1,600 dyne s cm-5. esCCO increased from 4.3 to 4.9 L/
min, even though an increase in esCCO preceded that of
the CCO, reflecting the time delay in CCO measurement
due to averaging (Fig. 3, Interval C).
2.3 Analysis of the time component
PWTT can be divided into the following 3 time-related
components (Fig. 1):
1. PEP: Pre-ejection period consisting of the electrome-
chanical delay at the start of systole and isometric
contraction time, with the R wave of ECG serving as
the starting point.
2. PWTT1: The time taken for pulse wave transmission
from the aorta through the elastic arteries to the
muscular arteries (namely, the radial artery).
3. PWTT2: The time taken for pulse wave transmission
from the radial artery to the further distal peripheral
site of SpO2 measurement.
As PEP and PWTT1 cannot be measured separately in the
esCCO method, PWTT was divided into two components:
PEP ? PWTT1, and PWTT2.
When SVR increased in Case 1, PWTT increased in
association with the decrease in SV and increase in MAP
(Fig. 4). Among the components tested, PEP ? PWTT1
remained unchanged, but PWTT2 increased during Interval
A. A similar pattern of change was observed during the
increase in SVR in Case 2 (Fig. 5, Interval B), even though
PEP ? PWTT1 tended to be slightly shorter.
When SVR decreased in Case 2, PWTT tended to be
shorter in association with the increasing tendency of SV
and the decreasing tendency of MAP (Fig. 6, Interval C).
Fig. 3 Trends in circulatory
parameters in Case 2 (Intervals
B and C) Blue heart rate (HR);
Red mean arterial pressure
(MAP); Green estimated
continuous cardiac output
(esCCO); Brown continuous
cardiac output derived from a
flow directional pulmonary
artery catheter (CCO); Purple
systemic vascular resistance
(SVR); Black pulse amplitude
(normalized SpO2 pulse wave
amplitude)
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Fig. 4 Trends in time-related components associated with stroke
volume and mean arterial pressure from 20:15 to 20:45 in Case 1
(Interval A). Left panel PWTT (PEP ? PWTT1 and PWTT2); Middle
panel stroke volume (SV); Right panel MAP. Bars in each column
show data obtained at 5-min intervals. Red arrows indicate directional
changes over time
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PEP ? PWTT1 showed a 1.10-fold prolongation at 19:30
compared with 18:00, and PWTT2 showed a 1.25-fold
shortening at 19:30 compared with 18:00.
2.4 Comment
Changes in SVR in both cases were confirmed by contin-
uous estimation of SVR as well as by continuous mea-
surement of the amplitude of the SpO2 pulse wave as
reported by Murray et al. [7]. Additionally, contributory
factors to induce changes in SVR were clearly identified in
both cases: switch from carbocaine to ropivacaine infusion
for case 1, and nicardipine injection for case 2, respec-
tively. Therefore, we believe that this case report could
preliminarily show the relationship between each compo-
nent of PWTT and SV during changes in SVR.
Although PEP was not assessed separately in the esCCO
system, PEP depends on changes in preload, afterload, and
cardiac contractility. Ronn et al. [8] reported that PEP
shortened when afterload was decreased by vasodilator
administration. The inotropic action of the heart mediated
by the carotid sinus reflex likely plays a role in this
shortening. On the other hand, Boudoulas et al. [9] reported
prolongation of PEP in relation to an elevation in isometric
contraction pressure following an increase in afterload
induced by vasoconstrictor administration. On the basis of
these findings, we speculate that an increase in afterload
prolongs PEP as observed in Case 1 (Fig. 4) and Case 2
(Fig. 5), while a decrease in afterload shortens PEP as
observed in Case 2 (Fig. 6).
PWTT1 indicates pulse wave transit time from pulse
waves arising from the aorta to the radial artery through
elastic and muscular arteries. The pulse wave velocity of
this time component is well known to correlate with arterial
capacitance [10] and to be a useful parameter for measur-
ing changes in arterial pressure [11]. When MAP increases,
the pulse wave velocity increases, resulting in shortening of
PWTT1 as observed in Case 1 (Fig. 4) and Case 2 (Fig. 5).
MAP [mmHg]
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PWTT SV MAP
Fig. 5 Trends of the time-related components associated with SV
and MAP from 16:50 to 17:20 in Case 2 (Interval B). Left panel
PWTT (PEP ? PWTT1 and PWTT2); Middle panel SV; Right panel
MAP. Bars in each column show data obtained at 5-min intervals.
Red arrows indicate directional changes over time
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Fig. 6 Trends in time-related components associated with SV and
MAP from 18:00 to 19:30 in Case 2 (Interval C). Left panel PWTT
(PEP ? PWTT1 and PWTT2); Middle panel SV; Right panel MAP.
Bars in each column show data obtained at 5-min intervals. Red
arrows indicate directional changes over time
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In contrast, when MAP decreases, the pulse wave velocity
decreases, resulting in prolongation of PWTT1 as observed
in Case 2. When observing opposite directional changes in
PEP and PWTT1 during changes in afterload, changes in
PEP ? PWTT1 are not obvious as observed in Case 1
(Fig. 4) and Case 2 (Figs. 5, 6), compared with changes
shown when each component is solely used to estimate SV.
PWTT2 indicates pulse wave transit time from the radial
artery to the further distal arterioles of the SpO2 detection
site. Pulse wave velocity in this part begins to decrease and
reflects an increase in viscosity as the vascular diameter
decreases [12]. Accordingly, prolongation of PWTT2 can
be expected when vasoconstriction occurs as observed in
Case 1 (Fig. 4) and Case 2 (Fig. 5). In contrast, shortening
of PWTT2 can be expected when vasodilation occurs as
observed in Case 2 (Fig. 6).
Considering these directional changes in the time com-
ponent of PWTT associated with changes in afterload,
PWTT2 is likely to have a significant impact on the deter-
mination of PWTT during changes in afterload. Sugo et al.
[3] analyzed the relationship of each of these components
with SV in an animal study, and they found that inclusion of
the PWTT2 component can improve the accuracy of SV
estimation after phenylephrine injection. If SV is estimated
solely from PWTT1, which reflects mainly arterial pressure
[11], overestimation of SV can be expected during vaso-
constriction accompanied by an increase in arterial pressure,
while the underestimation during vasodilatation is associ-
ated with a decrease in arterial pressure. In fact, Meng et al.
[2] reported that the trending ability of CO derived from
arterial waveform analysis versus CO derived from esoph-
ageal Doppler was only 23 % after phenylephrine treatment,
even though the former accurately tracked changes in CO
when preload changed. It seems that the inclusion of PEP and
PWTT2 can help promote the accuracy of estimating SV
based on PWTT when changes in SVR occur.
There were limitations in this report in addition to a small
sample size. First, data of this report were not derived from a
prospective clinical study, and it is thus difficult to draw any
definite conclusion, even though a canine experimental study
on SV estimation after phenylephrine injection supported the
hypothesis [3]. Therefore, further prospective clinical stud-
ies are required to test the hypothesis by simultaneously
measuring MAP, CVP and well accepted CCO in compari-
son with esCCO. Second, the impact of changes in SVR on
CO is only partially understood and consequently any con-
clusion based on simple observation is difficult. In fact, we
could find only two cases where changes in SVR mainly
affected changes in CO, since various factors other than
afterload may also have a significant impact on determining
CO particularly in our previous multi-center study [4].
In summary, data of this report suggest that the time
component of PWTT may improve the accuracy of CCO
estimation during changes in SVR. However, further pro-
spective clinical studies are required to test this hypothesis.
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